DGFT lifts export restriction on 12 molecules; paracetamol, HCQ on license basis
Ritonavir and Lopinavir will remain on the restricted list
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
APIs
No shortage of APIs and formulations in the country, says Government
NPPA has informed that they have not received any reference regarding shortage of active pharmaceutical ingredients. IDMA has…
COVID-19 outbreak credit neutral for pharma companies for now: Ind-Ra
This is despite the sector's heavy reliance on Chinese API and intermediates Ind-Ra has said that the new coronavirus…
Exports of certain APIs, formulations put under restricted category
APIs, formulations, Paracetamol, Vitamin B1 ,B12, coronavirus
2019-nCoV, nitrosamine issues trigger supply chain re-jigs
API manufacturers will have to up their quality game to compete with the new competitors The 2019-nCoV infection, which has…
USFDA completes inspection of Unichem Lab’s Roha facility with no observation
The US health regulator conducted inspection at the company's active pharmaceutical ingredients (APls) manufacturing unit at Roha…
Govt taking steps to reduce country’s dependence on imports of antibiotic raw materials
"The policies formulated by Government from time to time are designed to minimize country's dependence on imports and to give…
Indian pharma exports may touch $22 billion in FY20: Pharmexcil
On exports to China and Japan markets, the official said the Japan market was basically not favourable for generic drugs and also…
Experts address impact of M&A in pharma and promoting API manufacturing in India
M&A report recommendations focused on pricing, production and availability, R&D and social consequences
In order to…
Granules India gets US FDA nod for generic Ibuprofen tabs
The tablets are used to treat fever, pain or inflammation in the US market Drug maker Granules India has received approval from…